What is Victoza?
Victoza is an injectable treatment for type 2 diabetes. It contains the active ingredient liraglutide.
When your blood sugar is too high, Victoza helps to lower it. It can be used with or instead of other diabetes medication like metformin.
Victoza also slows the journey of food through your stomach, which helps to regulate your blood sugar. Eating a healthy diet, along with losing weight, can help your blood sugar levels stay balanced. Increasing your activity levels and reducing your fat, sugar and salt intake, along with using treatments like Victoza, can improve your health in the long-term and help you keep on top of your diabetes.[1]
How does Victoza work?
The active ingredient in Victoza is liraglutide. Sugar is extracted from the bloodstream by the hormone insulin which is produced by the pancreas. Liraglutide encourages the production of insulin by the pancreas, resulting in more sugar being removed from your blood.
Liraglutide also slows the speed at which your stomach empties, which means that the sugar from the food is taken in at a slower rate, helping to decrease spikes in your blood sugar levels. This slowing of the digestion process also helps make your brain think that your stomach is full for longer, which helps with healthy eating and weight loss.[2]
What doses of Victoza are there?
The amount of Victoza that you use can vary from person to person. The starting dose is usually 0.6 mg once a day, for one week. This dosage can be increased to 1.2 mg once a day under the guidance of our clinician. Our doctor may decide that you need to increase to 1.8 mg of Victoza once a day, if that is what is required to control your blood sugar effectively.
You don’t need to worry about getting it wrong when using the pen. The Victoza pen contains 18 mg of liraglutide and is designed so that you can easily choose which dosage you require: 0.6 mg, 1.2 mg, or 1.8 mg. Always follow our doctor’s instructions with it.
Treated trusted source:
- CDC (2024). About Type 2 Diabetes. Diabetes.
- Mehta, A., et al. (2017). “Liraglutide for weight management: a critical review of the evidence.” Obesity science & practice.
This page was medically reviewed by
Dr Daniel Atkinson on July 24, 2024. Next review due on
July 24, 2027.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.